Niceritrol

Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	C10AD01 (WHO)
Identifiers
IUPAC name 3-[(pyridin-3-yl)carbonyloxy]-2,2-bis({[(pyridin-3-yl)carbonyloxy]methyl})propyl pyridine-3-carboxylate
CAS Number	5868-05-3 Y
PubChem CID	4476
ChemSpider	4321 N
UNII	F54EHJ34MV
KEGG	D01754 Y
CompTox Dashboard (EPA)	DTXSID1023364
ECHA InfoCard	100.025.017
Chemical and physical data
Formula	C29H24N4O8
Molar mass	556.531 g·mol−1
3D model (JSmol)	Interactive image
SMILES C1=CC(=CN=C1)C(=O)OCC(COC(=O)C2=CN=CC=C2)(COC(=O)C3=CN=CC=C3)COC(=O)C4=CN=CC=C4
InChI InChI=1S/C29H24N4O8/c34-25(21-5-1-9-30-13-21)38-17-29(18-39-26(35)22-6-2-10-31-14-22,19-40-27(36)23-7-3-11-32-15-23)20-41-28(37)24-8-4-12-33-16-24/h1-16H,17-20H2 N Key:KUEUWHJGRZKESU-UHFFFAOYSA-N N
NY (what is this?)  (verify)

Niceritrol is a niacin derivative used as a hypolipidemic agent. It is an ester of pentaerythritol and nicotinic acid, has general properties similar to those of nicotinic acid (Nicotinamide), to which it is slowly hydrolysed. Niceritrol has been used as a lipid regulating drug in hyperlipidaemias and as a vasodilator in the treatment of peripheral vascular disease.^[1][2]

References[edit]